Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: December 2017

12/27/2017 Database Update: Pharmaceutical Drug Production in Russia (November 2017)

Between January and November 2017, Russia produced 302 bln RUB worth of pharmaceuticals (dispatch prices, VAT included), which is 5.9% higher than that of the same period last year (in RUB). The progress in physical terms amounts only to 2%, as Russia has manufactured 4.1 bln units of drugs.

12/20/2017 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (November 2017)

Between January and November 2017, Russia imported 29 bln RUB worth of feed supplements (free circulation prices), which is a 5.1% increase in monetary terms against the same period of 2016. The import of veterinary drugs amounted to 20.7 bln RUB, with a 4.8% increase. The veterinary API import had the biggest progress, with 12.7% and 1.6 bln RUB.

12/19/2017 Database Update: Pharmaceutical Drug Import to Russia (November 2017)

Over the first 11 months of 2017, Russia imported 557.8 bln RUB worth of pharmaceutical drugs (free circulation prices, VAT included), which is a 4.3% increase against the same period of 2016. The import of ready-made drugs has increased by 9.2% and amounts to 472.2 bln RUB. The import of in-bulk products account for 85.6 bln RUB, with the decline by 16.4%.